Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14132-14141
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14132
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14132
Study | Country | Start year | Phase | Study design | Inclusion | Sample size | Primary endpoint |
KLASS-01 | South Korea | 2006 | III | LADG vs ODG | cT1-2/N0 | 1400 | Overall survival |
JCOG 0912 | Japan | 2010 | III | LADG vs ODG | cT1-2/N0 | 920 | Overall survival |
JLSSG 0901 | Japan | 2010 | II/III | LADG vs ODG | cT2-4a/N0-2/M0 | II: 180 | II: Morbidity |
III: 500 | III: Relapse-free survival | ||||||
KLASS-02 | South Korea | 2011 | III | LADG vs ODG | cT2-4a/N0-4a/M0 | 1050 | 3-yr DFS |
CLASS-01 | China | 2012 | III | LADG vs ODG | cT2-4a/N0-4a/M0 | 1056 | 3-yr DFS |
COACT 1001 | South Korea | 2010 | III | LADG vs ODG | cT2-4a/N0-3a/M0 | 204 | Noncompliance rate |
KRGS | South Korea | 2011 | II | Robot vs Laparoscopy | cT1-3/M0 | 1700 | Surgical outcomes |
SENORITA | South Korea | 2012 | III | Laparoscopic SNNS | cT1-2/N0/size < 4 cm | 160 | Safety/efficacy |
- Citation: Son SY, Kim HH. Minimally invasive surgery in gastric cancer. World J Gastroenterol 2014; 20(39): 14132-14141
- URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i39.14132